The VPA Circular provides regular updates on regulatory matters, professional standards, and emerging industry issues to ensure stakeholders remain informed and compliant with their obligations.
The VPA Circular provides regular updates on regulatory matters, professional standards, and emerging industry issues to ensure stakeholders remain informed and compliant with their obligations. This includes essential information regarding statutory requirements, policy developments, and best practice standards to the pharmacy sector.
Welcome to the VPA’s December circular.
In this circular, we include information on the VPA’s approach to pharmacy franchising in the context of recent industry developments. On behalf of the members of the VPA, I reiterate our ongoing commitment to ensuring that all Victorian pharmacies are owned, operated and controlled only by registered pharmacists.
Other focus areas relate to compounding, including sterile compounding, and medicinal cannabis. We highlight important considerations for pharmacists considering compounding medicinal cannabis, and information on sterile compounding following the recent TGA alert about compounded semaglutide-like products. There is also important information about holding stock of medicinal cannabis.
A highlight of this year has been the introduction of a new, improved inspection program, which focuses on compliance with the VPA Standards. We look forward to providing further information about our new approach to inspections in the new year.
At this time of the year, we remind proprietors to renew your AHPRA registration by 31 December if you haven‘t already done so, given the significant implications of a lapsed registration on a licensee’s eligibility to continue to hold a pharmacy business licence.
On behalf of the VPA members and staff, I wish you a happy and safe festive season and best wishes for the new year.
David McConville
Chair
